#5 - Agilent Technologies (NYSE:A)
Agilent Technologies Inc. (NYSE: A) provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. This is a market that grew from approximately $4.7 billion in 2022 to approximately $5.07 billion in 2023. And the market is expected to grow at a compound annual growth rate (CAGR) of 8.1% to around $6.8 billion in 2027.
For its part, Agilent has a strategic agreement with PathAi in which Agilent will provide "an end-to-end solution for AI-powered assay development, including companion diagnostics enabled by digital pathology." This part of PathAI's precision medicine strategy which is likely to be one of the most investable themes in the next decade or more.
At 26x forward earnings, Agilent stock is expensive compared to the average of the S&P 500. And the company has been missing topline estimates from the prior year in the last four quarters. That may explain why analysts have a consensus Moderate Buy rating on A stock with a price target of $140.71. That would suggest that investors may want to wait for the stock to pull back.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Read More - Current Price
- $127.07
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 8 Buy Ratings, 5 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $144.36 (13.6% Upside)
